Integra LifeSciences (IART) continues to face operational and execution challenges, with shares underperforming and management credibility under pressure after repeated guidance cuts. While IART's ...

A feasibility study for Integra Resources’ (TSXV: ITR; NYSE-A: ITRG) DeLamar gold-silver project in Idaho lifts potential profit, trims construction and shortens payback, CEO George Salamis says. At ...

The Acura Integra marks its 40th birthday in 2026. If you, like the Integra (and in fact, the whole Acura brand), were born in 1986, I apologize for reminding you of the inescapable passage of time, ...

Integra Solutions wants to take on one of Miami-Dade’s biggest public housing overhauls, proposing a $385.9 million redevelopment that would quintuple density on a 12-acre Brownsville site while ...

The new Prelude hybrid coupe might be stealing the spotlight in Honda’s current lineup, but another model is trying hard to edge into view at the Guangzhou Auto Show in China. Let’s be clear that the ...

Price: The 2023 Acura Integra starts at $30,800. The 2023 Acura Integra is an all-new premium compact sedan and the most affordable new Acura. It revives a name from the days when Acura had more ...

Integra LifeSciences Holdings (IART) remains unprofitable, with losses accelerating at a 59% per year pace over the last five years. Revenue is forecast to grow just 2.5% annually, trailing the ...

Integra LifeSciences Holdings (IART) reported its third-quarter 2025 earnings, surpassing earnings per share (EPS) expectations but missing revenue forecasts. The company posted an adjusted EPS of ...

Integra LifeSciences Holdings (IART) has posted a modest move recently, gaining 3% over the past week and climbing 35% in the past 3 months. However, the stock's long-term returns tell a different ...

Daylight is one of the most effective tools in architecture. It creates atmosphere, improves comfort, and reduces energy demand. However, integrating daylight successfully requires precision at every ...

Integra LifeSciences remains deeply discounted due to ongoing operational setbacks, with the market adopting a cautious 'show me' stance until clear improvements emerge. Remediation and margin ...